ZNF658's activity is intricately tied to its ability to bind DNA, a function that is modulated by various biochemical mechanisms. One such mechanism involves the elevation of intracellular cAMP levels, which can be achieved through the activation of adenylyl cyclase or the inhibition of phosphodiesterases. The resulting increase in cAMP is known to promote phosphorylation events within the cell that can enhance the DNA-binding activity of zinc finger proteins like ZNF658. Additionally, the provision of essential zinc ions is critical for the proper folding and function of ZNF658, ensuring its structural integrity and ability to interact with DNA effectively. The chromatin environment also plays a pivotal role in ZNF658's function. Compounds that inhibit histone deacetylases or DNA methyltransferases can lead to a more relaxed chromatin state and reduced methylation levels, respectively, both of which may facilitate ZNF658's access to DNA and thus augment its activity.
Beyond the direct modulation of chromatin dynamics, ZNF658 function is also influenced by broader cellular signaling pathways that govern gene expression and proteostasis. The inhibition of GSK-3, for instance, activates the Wnt pathway, which can indirectly enhance ZNF658 activity by altering the cellular context in which it operates. Similarly, mTOR inhibition can lead to changes in transcriptional programs that could increase the role of ZNF658 in gene regulation. The cellular response to stress, such as altered proteostasis through proteasome inhibition, can also increase the levels of regulatory proteins, potentially enhancing ZNF658's functional activity. Furthermore, metabolic alterations induced by AMPK activators may affect the cellular energy state and gene expression patterns, which can have downstream effects on ZNF658's activity.
SEE ALSO...
Items 1 to 10 of 11 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
IBMX | 28822-58-4 | sc-201188 sc-201188B sc-201188A | 200 mg 500 mg 1 g | $260.00 $350.00 $500.00 | 34 | |
Non-specific inhibitor of phosphodiesterases, leading to increased cAMP levels which can enhance the activity of ZNF658 through cAMP-dependent pathways. | ||||||
Zinc | 7440-66-6 | sc-213177 | 100 g | $48.00 | ||
Provides zinc ions necessary for the proper folding and function of ZNF658, which is a zinc finger protein, thus potentially increasing its DNA-binding activity. | ||||||
Trichostatin A | 58880-19-6 | sc-3511 sc-3511A sc-3511B sc-3511C sc-3511D | 1 mg 5 mg 10 mg 25 mg 50 mg | $152.00 $479.00 $632.00 $1223.00 $2132.00 | 33 | |
Histone deacetylase inhibitor which can lead to a more relaxed chromatin structure, potentially enhancing ZNF658's access to DNA and increasing its activity. | ||||||
5-Azacytidine | 320-67-2 | sc-221003 | 500 mg | $280.00 | 4 | |
DNA methyltransferase inhibitor that may result in hypomethylation of DNA, possibly facilitating ZNF658 binding to its target genes thereby increasing its activity. | ||||||
Sodium Butyrate | 156-54-7 | sc-202341 sc-202341B sc-202341A sc-202341C | 250 mg 5 g 25 g 500 g | $31.00 $47.00 $84.00 $222.00 | 19 | |
Histone deacetylase inhibitor that can cause chromatin remodeling, possibly enhancing the DNA-binding ability of ZNF658. | ||||||
Retinoic Acid, all trans | 302-79-4 | sc-200898 sc-200898A sc-200898B sc-200898C | 500 mg 5 g 10 g 100 g | $66.00 $325.00 $587.00 $1018.00 | 28 | |
A metabolite of Vitamin A that can influence gene expression and may enhance ZNF658 activity by affecting gene regulatory mechanisms in which ZNF658 is involved. | ||||||
Lithium | 7439-93-2 | sc-252954 | 50 g | $214.00 | ||
Inhibits GSK-3 leading to Wnt pathway activation, which may indirectly increase ZNF658 activity by modulating cellular contexts where ZNF658 is functionally relevant. | ||||||
Rapamycin | 53123-88-9 | sc-3504 sc-3504A sc-3504B | 1 mg 5 mg 25 mg | $63.00 $158.00 $326.00 | 233 | |
mTOR inhibitor that can alter transcriptional programs, potentially increasing ZNF658's role in gene regulation under conditions of reduced mTOR activity. | ||||||
MG-132 [Z-Leu- Leu-Leu-CHO] | 133407-82-6 | sc-201270 sc-201270A sc-201270B | 5 mg 25 mg 100 mg | $60.00 $265.00 $1000.00 | 163 | |
Proteasome inhibitor that can lead to increased levels of regulatory proteins, potentially enhancing ZNF658's activity via altered proteostasis. | ||||||
AICAR | 2627-69-2 | sc-200659 sc-200659A sc-200659B | 50 mg 250 mg 1 g | $65.00 $280.00 $400.00 | 48 | |
AMPK activator that may promote metabolic changes affecting ZNF658's activity by altering the cellular energy state and gene expression patterns. | ||||||